We examined the effects of gut microbial catabolites of tryptophan on the aryl hydrocarbon receptor (AhR). Using a reporter gene assay, we show that all studied catabolites are low-potency agonists of human AhR. The efficacy of catabolites differed substantially, comprising agonists with no or low (i3-propionate, i3-acetate, i3-lactate, i3-aldehyde), medium (i3-ethanol, i3-acrylate, skatole, tryptamine), and high (indole, i3-acetamide, i3-pyruvate) efficacies. We displayed ligand-selective antagonist activities by i3-pyruvate, i3-aldehyde, indole, skatole, and tryptamine. Ligand binding assay identified low affinity (skatole, i3-pyruvate, and i3-acetamide) and very low affinity (i3-acrylate, i3-ethanol, indole) ligands of the murine AhR. Indole, skatole, tryptamine, i3-pyruvate, i3-acrylate, and i3-acetamide induced CYP1A1 mRNA in intestinal LS180 and HT-29 cells, but not in the AhR-knockout HT-29 variant. We observed a similar CYP1A1 induction pattern in primary human hepatocytes. The most AhR-active catabolites (indole, skatole, tryptamine, i3-pyruvate, i3-acrylate, i3-acetamide) elicited nuclear translocation of the AhR, followed by a formation of AhR-ARNT heterodimer and enhanced binding of the AhR to the CYP1A1 gene promoter. Collectively, we comprehensively characterized the interactions of gut microbial tryptophan catabolites with the AhR, which may expand the current understanding of their potential roles in intestinal health and disease.

Department of Cell Biology and Genetics Faculty of Science Palacky University Slechtitelu 27 783 71 Olomouc Czech Republic

Department of Cytokinetics Institute of Biophysics of the Czech Academy of Sciences Královopolská 135 61265 Brno Czech Republic

Department of Genetics and Department of Medicine Albert Einstein College of Medicine Bronx NY 10461 USA

Division of Biologically Active Complexes and Molecular Magnets Regional Centre of Advanced Technologies and Materials Faculty of Science Palacký University Šlechtitelů 27 783 71 Olomouc Czech Republic

See more in PubMed

Sivaprakasam S., Bhutia Y.D., Ramachandran S., Ganapathy V. Cell-Surface and Nuclear receptors in the colon as targets for bacterial metabolites and its relevance to colon health. Nutrients. 2017;9 doi: 10.3390/nu9080856. PubMed DOI PMC

Roager H.M., Licht T.R. Microbial tryptophan catabolites in health and disease. Nat. Commun. 2018;9:3294. doi: 10.1038/s41467-018-05470-4. PubMed DOI PMC

Gutierrez-Vazquez C., Quintana F.J. Regulation of the immune response by the aryl hydrocarbon receptor. Immunity. 2018;48:19–33. doi: 10.1016/j.immuni.2017.12.012. PubMed DOI PMC

Bock K.W. Human and rodent aryl hydrocarbon receptor (AHR): From mediator of dioxin toxicity to physiologic AHR functions and therapeutic options. Biol. Chem. 2017;398:455–464. doi: 10.1515/hsz-2016-0303. PubMed DOI

Venkatesh M., Mukherjee S., Wang H., Li H., Sun K., Benechet A.P., Qiu Z., Maher L., Redinbo M.R., Phillips R.S., et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and Toll-like receptor 4. Immunity. 2014;41:296–310. doi: 10.1016/j.immuni.2014.06.014. PubMed DOI PMC

Qiu Z., Cervantes J.L., Cicek B.B., Mukherjee S., Venkatesh M., Maher L.A., Salazar J.C., Mani S., Khanna K.M. Pregnane X receptor regulates pathogen-induced inflammation and host defense against an intracellular bacterial infection through toll-like receptor 4. Sci. Rep. 2016;6:31936. doi: 10.1038/srep31936. PubMed DOI PMC

Hakkola J., Rysa J., Hukkanen J. Regulation of hepatic energy metabolism by the nuclear receptor PXR. Biochim. Biophys. Acta. 2016;1859:1072–1082. doi: 10.1016/j.bbagrm.2016.03.012. PubMed DOI

Stejskalova L., Dvorak Z., Pavek P. Endogenous and exogenous ligands of aryl hydrocarbon receptor: Current state of art. Curr. Drug Metab. 2011;12:198–212. doi: 10.2174/138920011795016818. PubMed DOI

Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003;43:309–334. doi: 10.1146/annurev.pharmtox.43.100901.135828. PubMed DOI

Abel J., Haarmann-Stemmann T. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 2010;391:1235–1248. doi: 10.1515/bc.2010.128. PubMed DOI

Adachi J., Mori Y., Matsui S., Takigami H., Fujino J., Kitagawa H., Miller C.A., III, Kato T., Saeki K., Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 2001;276:31475–31478. doi: 10.1074/jbc.C100238200. PubMed DOI

Sinal C.J., Bend J.R. Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin in mouse hepatoma hepa 1c1c7 cells. Mol. Pharmacol. 1997;52:590–599. doi: 10.1124/mol.52.4.590. PubMed DOI

Chen I., McDougal A., Wang F., Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis. 1998;19:1631–1639. doi: 10.1093/carcin/19.9.1631. PubMed DOI

Chowdhury G., Dostalek M., Hsu E.L., Nguyen L.P., Stec D.F., Bradfield C.A., Guengerich F.P. Structural identification of Diindole agonists of the aryl hydrocarbon receptor derived from degradation of indole-3-pyruvic acid. Chem. Res. Toxicol. 2009;22:1905–1912. doi: 10.1021/tx9000418. PubMed DOI PMC

Chen I., Safe S., Bjeldanes L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem. Pharmacol. 1996;51:1069–1076. doi: 10.1016/0006-2952(96)00060-3. PubMed DOI

Schroeder J.C., Dinatale B.C., Murray I.A., Flaveny C.A., Liu Q., Laurenzana E.M., Lin J.M., Strom S.C., Omiecinski C.J., Amin S., et al. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry. 2010;49:393–400. doi: 10.1021/bi901786x. PubMed DOI PMC

Rothhammer V., Mascanfroni I.D., Bunse L., Takenaka M.C., Kenison J.E., Mayo L., Chao C.C., Patel B., Yan R., Blain M., et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 2016;22:586–597. doi: 10.1038/nm.4106. PubMed DOI PMC

Helferich W.G., Denison M.S. Ultraviolet photoproducts of tryptophan can act as dioxin agonists. Mol. Pharmacol. 1991;40:674–678. PubMed

Bergander L., Wahlstrom N., Alsberg T., Bergman J., Rannug A., Rannug U. Characterization of in vitro metabolites of the aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b]carbazole by liquid chromatography-mass spectrometry and NMR. Drug Metab. Dispos. Biol. Fate Chem. 2003;31:233–241. doi: 10.1124/dmd.31.2.233. PubMed DOI

DeGroot D.E., Franks D.G., Higa T., Tanaka J., Hahn M.E., Denison M.S. Naturally occurring marine brominated indoles are aryl hydrocarbon receptor ligands/agonists. Chem. Res. Toxicol. 2015;28:1176–1185. doi: 10.1021/acs.chemrestox.5b00003. PubMed DOI PMC

Heath-Pagliuso S., Rogers W.J., Tullis K., Seidel S.D., Cenijn P.H., Brouwer A., Denison M.S. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry. 1998;37:11508–11515. doi: 10.1021/bi980087p. PubMed DOI

Hubbard T.D., Murray I.A., Bisson W.H., Lahoti T.S., Gowda K., Amin S.G., Patterson A.D., Perdew G.H. Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep. 2015;5:12689. doi: 10.1038/srep12689. PubMed DOI PMC

Rasmussen M.K., Balaguer P., Ekstrand B., Daujat-Chavanieu M., Gerbal-Chaloin S. Skatole (3-Methylindole) is a partial Aryl hydrocarbon receptor agonist and induces CYP1A1/2 and CYP1B1 expression in primary human hepatocytes. PLoS ONE. 2016;11:e0154629. doi: 10.1371/journal.pone.0154629. PubMed DOI PMC

Stepankova M., Bartonkova I., Jiskrova E., Vrzal R., Mani S., Kortagere S., Dvorak Z. Methylindoles and methoxyindoles are agonists and antagonists of human Aryl hydrocarbon receptor. Mol. Pharmacol. 2018;93:631–644. doi: 10.1124/mol.118.112151. PubMed DOI PMC

Jin U.H., Lee S.O., Sridharan G., Lee K., Davidson L.A., Jayaraman A., Chapkin R.S., Alaniz R., Safe S. Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities. Mol. Pharmacol. 2014;85:777–788. doi: 10.1124/mol.113.091165. PubMed DOI PMC

Zelante T., Iannitti R.G., Cunha C., De Luca A., Giovannini G., Pieraccini G., Zecchi R., D’Angelo C., Massi-Benedetti C., Fallarino F., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity. 2013;39:372–385. doi: 10.1016/j.immuni.2013.08.003. PubMed DOI

Lamas B., Richard M.L., Leducq V., Pham H.P., Michel M.L., Da Costa G., Bridonneau C., Jegou S., Hoffmann T.W., Natividad J.M., et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 2016;22:598–605. doi: 10.1038/nm.4102. PubMed DOI PMC

Hubbard T.D., Murray I.A., Perdew G.H. Indole and tryptophan metabolism: Endogenous and dietary routes to Ah receptor activation. Drug Metab. Dispos. Biol. Fate Chem. 2015;43:1522–1535. doi: 10.1124/dmd.115.064246. PubMed DOI PMC

Gao J., Xu K., Liu H., Liu G., Bai M., Peng C., Li T., Yin Y. Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front. Cell. Infect. Microbiol. 2018;8:13. doi: 10.3389/fcimb.2018.00013. PubMed DOI PMC

Oberg M., Bergander L., Hakansson H., Rannug U., Rannug A. Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol. Sci. Off. J. Soc. Toxicol. 2005;85:935–943. doi: 10.1093/toxsci/kfi154. PubMed DOI

Yu J., Luo Y., Zhu Z., Zhou Y., Sun L., Gao J., Sun J., Wang G., Yao X., Li W. A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor. J. Allergy Clin. Immunol. 2019;143:2108–2119.e12. doi: 10.1016/j.jaci.2018.11.036. PubMed DOI

Vyhlidalova B., Poulikova K., Bartonkova I., Krasulova K., Vanco J., Travnicek Z., Mani S., Dvorak Z. Mono-methylindoles induce CYP1A genes and inhibit CYP1A1 enzyme activity in human hepatocytes and HepaRG cells. Toxicol. Lett. 2019;313:66–76. doi: 10.1016/j.toxlet.2019.06.004. PubMed DOI PMC

Dvorak Z., Kopp F., Costello C.M., Kemp J.S., Li H., Vrzalova A., Stepankova M., Bartonkova I., Jiskrova E., Poulikova K., et al. Targeting the pregnane X receptor using microbial metabolite mimicry. EMBO Mol. Med. 2020:e11621. doi: 10.15252/emmm.201911621. PubMed DOI PMC

Metidji A., Omenetti S., Crotta S., Li Y., Nye E., Ross E., Li V., Maradana M.R., Schiering C., Stockinger B. The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity. Immunity. 2018;49:353–362.e5. doi: 10.1016/j.immuni.2018.07.010. PubMed DOI PMC

Novotna A., Pavek P., Dvorak Z. Novel stably transfected gene reporter human hepatoma cell line for assessment of aryl hydrocarbon receptor transcriptional activity: Construction and characterization. Environ. Sci. Technol. 2011;45:10133–10139. doi: 10.1021/es2029334. PubMed DOI

Kubesova K., Travnicek Z., Dvorak Z. Pleiotropic effects of gold(I) mixed-ligand complexes of 9-deazahypoxanthine on transcriptional activity of receptors for steroid hormones, nuclear receptors and xenoreceptors in human hepatocytes and cell lines. Eur. J. Med. Chem. 2016;121:530–540. doi: 10.1016/j.ejmech.2016.05.064. PubMed DOI

Denison M.S., Rogers J.M., Rushing S.R., Jones C.L., Tetangco S.C., Heath-Pagliuso S. Analysis of the aryl hydrocarbon receptor (AhR) signal transduction pathway. Curr. Protoc. Toxicol. 2002;11 doi: 10.1002/0471140856.tx0408s11. PubMed DOI

Jasmone Is a Ligand-Selective Allosteric Antagonist of Aryl Hydrocarbon Receptor (AhR)

Microbial Metabolites as Ligands to Xenobiotic Receptors: Chemical Mimicry as Potential Drugs of the Future

Mixture Effects of Tryptophan Intestinal Microbial Metabolites on Aryl Hydrocarbon Receptor Activity

Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands

Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells

Drug Mimicry: Promiscuous Receptors PXR and AhR, and Microbial Metabolite Interactions in the Intestine

Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize Drugs